Sunto-g, Japan
A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments
Phase
2Span
79 weeksSponsor
H. Lundbeck A/SKasuga, Fukuoka
Recruiting
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes
Phase
3Span
321 weeksSponsor
Merck Sharp & Dohme LLCKasuga, Fukuoka
Recruiting
1-2 of 2